Doximity vs Veeva Systems: Which Is the Stronger Buy Today?
Veeva Systems fell -12% during the past Week. You may be tempted to buy more, or may want to reduce your exposure. But there is an entirely different perspective you might be missing. Is there a better alternative? Turns out, its peer Doximity gives you more. Doximity (DOCS) stock offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Veeva Systems (VEEV) stock, suggesting you may be better off investing in DOCS
- DOCS’s quarterly revenue growth was 23.2%, vs. VEEV’s 16.7%.
- In addition, its Last 12 Months revenue growth came in at 20.2%, ahead of VEEV’s 15.3%.
- DOCS leads on profitability over both periods – LTM margin of 39.7% and 3-year average of 36.9%.
These differences become even clearer when you look at the financials side by side. The table highlights how VEEV’s fundamentals stack up against those of DOCS on growth, margins, momentum, and valuation multiples.
Valuation & Performance Overview
| VEEV | DOCS | Preferred | |
|---|---|---|---|
| Valuation | |||
| P/EBIT Ratio | 49.1 | 38.8 | DOCS |
| Revenue Growth | |||
| Last Quarter | 16.7% | 23.2% | DOCS |
| Last 12 Months | 15.3% | 20.2% | DOCS |
| Last 3 Year Average | 14.1% | 17.4% | DOCS |
| Operating Margins | |||
| Last 12 Months | 26.9% | 39.7% | DOCS |
| Last 3 Year Average | 22.5% | 36.9% | DOCS |
| Momentum | |||
| Last 3 Year Return | 29.2% | 61.4% | DOCS |
Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: VEEV Revenue Comparison | DOCS Revenue Comparison
See more margin details: VEEV Operating Income Comparison | DOCS Operating Income Comparison
See detailed fundamentals on Buy or Sell DOCS Stock and Buy or Sell VEEV Stock. Below we compare market return and related metrics across years.
Historical Market Performance
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | Avg | Best | |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| VEEV Return | 94% | -6% | -37% | 19% | 9% | 12% | 68% | ||
| DOCS Return | – | – | -33% | -16% | 90% | -4% | 2% | ||
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 15% | 109% | <=== | |
| Monthly Win Rates [3] | |||||||||
| VEEV Win Rate | 67% | 58% | 33% | 50% | 58% | 60% | 54% | ||
| DOCS Win Rate | – | 33% | 25% | 50% | 67% | 50% | 38% | ||
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 70% | 64% | <=== | |
| Max Drawdowns [4] | |||||||||
| VEEV Max Drawdown | -14% | -11% | -41% | -2% | -11% | -0% | -13% | ||
| DOCS Max Drawdown | – | – | -52% | -41% | -18% | -13% | -21% | ||
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | -12% | <=== | |
[1] Cumulative total returns since the beginning of 2020
[2] 2025 data is for the year up to 11/25/2025 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read DOCS Dip Buyer Analyses and VEEV Dip Buyer Analyses to see how these stocks have fallen and recovered in the past.
Still not sure about VEEV or DOCS? Consider portfolio approach.
Portfolios Over Individual Stock Picks
Stocks can jump or crash but long term success comes from staying invested. The right portfolio helps you ride gains and cushion single stock drops
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.